A bill bolstering a federal drug discount program that conservative critics have warned is a backdoor effort to subsidize transgender treatments for minors passed in the Oklahoma Senate last week, as similar measures are making their way through other Republican-led state legislatures.

Conservative critics who oppose legislative expansions to the 340B drug pricing program have warned that bolstering the program could undermine President Donald Trump’s executive orders cutting off taxpayer funding for abortions, “sex-change” procedures performed on minors, and benefits for illegal immigrants.